StemRNA™ Human iPSC 771-3G

Ready-to-use iPSCs made using the Cutting-Edge StemRNA 3^rd Gen Reprogramming Technology

 Taking full advantage of the power of the  3rd Gen Technology, these cells feature:

• No possibility of integration or retention of Reprogramming Vectors
• Immediate thawing into NutriStem hPSC XF Culture medium (Cat. No. 01-0005) in iMatrix-511 substrate (Cat. No. NP892-011) with easy conversion to other standard iPSC media.
• The possibility of saving significant time compared to reprogramming your own cells.

 Find out more about the benefits of our other StemRNA human iPSCs. 

RPChiPS7713G1 Cells were cultured in NutriStem hPSC XF Medium
on iMatrix-511 and stained for common pluripotency markers and DAPI.

Stemgent and the StemRNA brand name are trademarks of REPROCELL Inc., Japan.

Product Name: StemRNA Human iPSC 771-3G

Catalog Number: RCRP005N

Product Description: Human iPS Cells established from endothelial progenitor cells (derived from peripheral blood), reprogrammed with the Stemgent StemRNA 3^rd Gen Reprogramming technology

Strain: RPChiPS7713G1

Passage Number: Passage 15

Donor Information:

• Race: Caucasian
• Sex: Male
• Age: 32 years old

Precryopreservation Culture Conditions:

• Culture Medium: NutriStem® hPSC XF Culture Medium (Cat. No. 01-0005)
• Culture Matrix: iMatrix-511 (Cat. No. NP892-011)
• Cryopreservation Medium: NutriFreez™ D10 Freezing Medium (Cat. No. 01-0020-50)

Size: 1 vial, 1 × 10⁶ cells per vial

Storage: Store in liquid nitrogen vapor phase.

Quality Control

• Pluripotency by ICC: Pass
• Viability: > 80 %
• Bacteria: Negative
• Mycoplasma: Negative
• Virus (HIV1&2, HBV, HCV, HTLV1&2, Parvovirus B19): Negative
• Karyotype: 46, XY

Sterility: Sterile

Notice To Purchaser: This product is intended for Research Use Only.  Commercial Use may require additional agreements. Please contact info-us@reprocell.com for more information.

Product Flyer:

• StemRNA™ Human iPSCs

Specification Sheets:

• RCRP005N Specifications Sheet

Protocol for Thawing and Passaging:

• Thawing StemRNA™ hiPSCs

Additional Publications

• Widley A; Harrington S; Steno-Bittel L; Daranu F. Reduction of Activin A gives rise to comparable expression of key definitive endoderm and mature beta cell markers. Future Medicine 19:47 (2024).
• Kaltak M; Blanco-Garavito R; Molday LL; Dhaenens C-M; Souied EE; Platenburg G; Swilden J; Molday RS; Cremers FPM. Stargardt disease-associated in-frame ABCA4 exon 17 skipping results in significant ABCA4 function. J Transl Med 21:546 (2023).
• Francois L; Boskovic P; Knerr J; Je W; Sigismondao G; Schwan C; More TH; Schlotter M; Krijgsveld J; Hiller K; Grosse R; lichter P; Radlwimmer B. BCAT1 redox function maintains mitotic fidelity. Cell Reports 41:111524 (2022).
• Shimada H; Sato Y; Sasaki T; Shimozawa A: imaizumi K; Shindo T; Miyao S; Kiyama K; Kondo T; Shibata S; Ishii S; Kuromitsu J; Aoyagi H; Ito D; Okano H. A next-generation iPSC-derived forebrain organoid model of tauopathy with tau fibrils by AAV-mediated gene transfer. Cell Reports Methods 2:100289 (2022).
• Park G; Shin M; Lee W; Hotta A; Kobayashi T; Kosodo Y. Direct visualization of the transition status during neural differentiation by dual-fluorescent reporter human pluripotent stem cells. Stem Cell Reports 17:1903 (2022).